Standard BioTools Balance Sheet Health
Financial Health criteria checks 5/6
Standard BioTools has a total shareholder equity of $163.2M and total debt of $63.5M, which brings its debt-to-equity ratio to 38.9%. Its total assets and total liabilities are $323.1M and $159.9M respectively.
Key information
38.9%
Debt to equity ratio
US$63.51m
Debt
Interest coverage ratio | n/a |
Cash | US$114.90m |
Equity | US$163.20m |
Total liabilities | US$159.87m |
Total assets | US$323.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: FLB's short term assets ($158.2M) exceed its short term liabilities ($109.3M).
Long Term Liabilities: FLB's short term assets ($158.2M) exceed its long term liabilities ($50.5M).
Debt to Equity History and Analysis
Debt Level: FLB has more cash than its total debt.
Reducing Debt: FLB's debt to equity ratio has reduced from 238.6% to 38.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FLB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: FLB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.8% each year